Abstract:To investigate the expression level of chloride intracellular channel 1 (CLIC1) and insulin-like growth factor binding protein 7 (IGFBP7) in complete hydatidiform mole (CHM) and estimate the relationship between the expression level and clinical prognosis.Immunohistochemistry (IHC) method was used to detect the expression level of P57(KIP2) in order to differentiate CHM. CLIC1 and IGFBP7 expression level of CHM were measured by IHC method then.(1) According to the P57(KIP2) expression result 66 patients were diagnosed as CHM (85.71%). Fourteen of 66 patients progressed into gestational trophoblastic neoplasia (GTN), which accounted for 21.21%. (2) The results of IHC showed that CLIC1 significantly higher expressed in malignant group than spontaneous regressive group (P = 0.014). IGFBP7 significantly down-regulated in malignant group (P = 0.002). (3) Pearson correlation analysis results revealed that there were no relation between the expression of CLIC1 and IGFBP7 (P = 0.761). Logistic regression analysis indicated that down-regulation of IGFBP7 was the independent risk factors of CHM progression, P = 0.005, OR = 8.493 (95% confidence interval (CI): 1.878-38.401); Serum hCG > 5 x 10(5) mIU/mL was the independent risk factors of CHM progression too, P = 0.011, OR = 11.251 (95% CI: 1.731-73.151). (4) Receiver operator characteristic curve (ROC curve) results showed that the area under the curve (AUC) of CLIC1 was 0.707. The optimum cut off was 10.5, and correspondingly sensitivity was 42.90%, specificity 94.20%. AUC of IGFBP7 was 0.764. The optimum cut off was 7.0, and the correspondingly sensitivity and specificity were 64.30% and 78.80% respectively. Combining the two markers in series, the sensitivity of predicting the prognosis of CHM was 21.42%, while the specificity was 100%. When combining in parallel, the sensitivity and specificity were 85.71% and 71.15% respectively.Up-regulation of CLIC1 and down-regulation of IGFBP7 might pay an important role in progression of CHM, but there was no relationship between the expression levels of them. The predictive values of malignance transformation of CHM with the two biomarkers were with certain accuracy, and combining them in parallel test could improve accuracy. They are promising to be candidate prognostic markers of CHM.

Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study.

Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia: PSCA and trophoblastic neoplasia

Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.

[Expression and Significance of LMP2 and PPM1A in Gestational Trophoblastic Disease].

Challenges in Diagnosing Hydatidiform Moles: a Review of Promising Molecular Biomarkers.

Identification of Microrna Signature in the Progression of Gestational Trophoblastic Disease

PTEN Promoter Methylation and Protein Expression in Normal Early Placentas and Hydatidiform Moles

[Expression of Laminin and Laminin Receptor in Gestational Trophoblastic Tumor and Its Significance].

Differential gene expression identified in complete hydatidiform mole by combining suppression subtractive hybridization and cDNA microarray.

[The Expression of EMT Associated Protein CK-18 and Vimentin in Gestational Trophoblastic Disease ].

Immunohistochemical and Mutational Analysis of P53 Tumor Suppressor Gene in Gestational Trophoblastic Disease: Correlation with Mdm2, Proliferation Index, and Clinicopathologic Parameters

Twin Pregnancy with Complete Hydatidiform Mole and Co-Existing Fetus: A Report of 15 Cases with a Clinicopathological Analysis and DNA Genotyping.

[Mismatch Repair Gene Promoter Methylation and Expression in Hydatidiform Moles and the Malignant Transformation].

Id helix-loop-helix proteins are differentially expressed in gestational trophoblastic disease

Methylation Status and Expression of E-cadherin and Cadherin-11 in Gestational Trophoblastic Diseases

Expression of TGF-beta Signaling Proteins in Normal Placenta and Gestational Trophoblastic Disease.

Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters.

Analysis of the Expression of Matrix Metalloproteinase and Tissue Inhibitor of Metalloproteinase in Gestational Trophoblastic Diseases

Expression of CLIC1 and IGFBP7 in Complete Hydatidiform Mole

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours

The expression of G1-S cell cycle inhibitors in normal placenta and gestational trophoblastic diseases